From 1ad96b785f7e52602da80635ed9017f83ee5bc45 Mon Sep 17 00:00:00 2001 From: Jingcheng Yang Date: Fri, 28 Jun 2024 13:17:25 -0400 Subject: [PATCH] Fix some bugs. --- docs/team_members.md | 26 +++++++++++++------------- 1 file changed, 13 insertions(+), 13 deletions(-) diff --git a/docs/team_members.md b/docs/team_members.md index e20e82e..58eb7d6 100644 --- a/docs/team_members.md +++ b/docs/team_members.md @@ -14,11 +14,11 @@ hide:
Jingcheng Yang
-
Post-doc Fellow - DryLab
+
Post-doc Fellow
- Post-doc Fellow, Harvard Medical School & MGH, Fudan University. He has earned a Ph.D. in Genetics from Fudan University. Prior to this, he was a cardiothoracic surgeon. Now, he focuses on integrating multi-omics data and knowledge graphs and conducts deep-learning heterogeneous network methods for network medicine to discover auto-immune disease mechanisms and potential treatments. Github >>> Research Gate + DryLab - Post-doc Fellow, Harvard Medical School & MGH, Fudan University. He has earned a Ph.D. in Genetics from Fudan University. Prior to this, he was a cardiothoracic surgeon. Now, he focuses on integrating multi-omics data and knowledge graphs and conducts deep-learning heterogeneous network methods for network medicine to discover auto-immune disease mechanisms and potential treatments. Github >>> Research Gate
@@ -26,11 +26,11 @@ hide:
Penghao xu
-
Post-doc Fellow - DryLab
+
Post-doc Fellow
- Post-doc Fellow, Georgia Tech. He has earned a Ph.D. in Bioinformatics from Georgia Tech in 2022. Prior to this, he received a Master’s degree in Computational Sciences and Engineering from Georgia Tech in 2019, and a Bachelor’s degree in Biological Sciences from Fudan University in 2017. His research area include Bioinformatics, Genomics, Data analysis, and Machine Learning. Github >>> Linkedin + DryLab - Post-doc Fellow, Georgia Tech. He has earned a Ph.D. in Bioinformatics from Georgia Tech in 2022. Prior to this, he received a Master’s degree in Computational Sciences and Engineering from Georgia Tech in 2019, and a Bachelor’s degree in Biological Sciences from Fudan University in 2017. His research area include Bioinformatics, Genomics, Data analysis, and Machine Learning. Github >>> Linkedin
@@ -38,11 +38,11 @@ hide:
Zihan Ran
-
Associate Professor - WetLab
+
Associate Professor
- She has earned a Ph.D. from Fudan University. She focuses on the health effects and toxicological mechanisms of pollutant exposure, knowledge graph and multi-omics data integration and analysis. + WetLab - She has earned a Ph.D. from Fudan University. She focuses on the health effects and toxicological mechanisms of pollutant exposure, knowledge graph and multi-omics data integration and analysis.
@@ -50,11 +50,11 @@ hide:
Feng Zhu
-
Ph.D. - WetLab
+
Ph.D.
- He is currently pursuing a Ph.D. at Fudan University. His research focuses on the development of CRISPR libraries and gene-editing cell libraries, as well as target and drug screening based on these technologies. + WetLab - He is currently pursuing a Ph.D. at Fudan University. His research focuses on the development of CRISPR libraries and gene-editing cell libraries, as well as target and drug screening based on these technologies.
@@ -62,23 +62,23 @@ hide:
Yechao Huang
-
Research Scientist - DryLab
+
Research Scientist
- He has earned a Ph.D. at the School of Life Sciences, Fudan University. He focuses on genomic structural variations in the human genome and population genetics. + DryLab - He has earned a Ph.D. at the School of Life Sciences, Fudan University. He focuses on genomic structural variations in the human genome and population genetics.
- +
Xiaofei Li
-
Ph.D. - WetLab
+
Ph.D.
- His primary research focus is to investigate the mechanisms of drug resistance in cancer and to explore the active components of traditional Chinese medicine, as well as repurposing existing drugs, utilizing knowledge graph techniques. + WetLab - His primary research focus is to investigate the mechanisms of drug resistance in cancer and to explore the active components of traditional Chinese medicine, as well as repurposing existing drugs, utilizing knowledge graph techniques.